Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara‐KRd), autologous hematopoietic cell transplantation, and measurable residual disease‐response‐adapted treatment cessation

Abstract Quadruplet induction, autologous hematopoietic cell transplant (AHCT), and measurable residual disease (MRD) response‐adapted consolidation yield an unprecedented depth of response in newly diagnosed multiple myeloma. Patients treated on MASTER (NCT03224507) ceased therapy and entered activ...

Полное описание

Библиографические подробности

Главные авторы:	Rebecca W. Silbermann, Timothy Martin Schmidt, Susan Bal, Binod Dhakal, Bhagirathbhai Dholaria, Eden Biltibo, Saurabh Chhabra, Smith Giri, Kelly N. Godby, Sonia Gowda, Eva Medvedova, Robert F. Cornell, Natalie S. Callander, Luciano J. Costa
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2023-08-01
Серии:	eJHaem
Предметы:	immunodeficiency measurable residual disease multiple myeloma
Online-ссылка:	https://doi.org/10.1002/jha2.736
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!